top of page

Selecting Biospecimens for Neuroscience Research

Choice Depends on the Research Question and the Accessibility of the Sample Type

Clinical biosamples serve as invaluable resources in neuroscience research, aiding our understanding of the brain's complex mechanisms and developing novel diagnostic and therapeutic strategies. This article will discuss the best clinical biosamples for neuroscience research, including cerebrospinal fluid, blood, brain tissue, saliva, and skin biopsies, while emphasizing the importance of the appropriate collection, storage, and handling procedures to maximize scientific outcomes. 

"As neuroscience research evolves, so will our understanding of the best clinical biosamples and the methods to maximize their scientific value."


Importance of clinical biosamples in neuroscience research

Clinical biosamples are crucial in neuroscience research, providing insights into the molecular, cellular, and physiological mechanisms underlying the nervous system's function and dysfunction. Analysing these samples helps researchers identify biomarkers and molecular signatures related to neurological diseases and develop novel diagnostic and therapeutic strategies. Additionally, clinical biosamples validate preclinical findings, bridging the gap between basic research and clinical applications.

Factors affecting the choice of biosamples

Selecting the appropriate clinical biosample depends on several factors, including:

  • The research question being addressed

  • The availability and accessibility of the sample type

  • The invasiveness of the collection method

  • The potential for longitudinal sampling

  • The reproducibility and reliability of the obtained data

Ethical considerations and consent

Ethical considerations are of paramount importance when obtaining clinical biosamples. Researchers must adhere to the principles of respect for autonomy, beneficence, non-maleficence, and justice, obtaining informed consent from participants and ensuring that an institutional review board approves the study.

Cerebrospinal Fluid (CSF)

Overview and relevance to neuroscience research

Cerebrospinal fluid (CSF) is a clear, colourless fluid found in the brain and spinal cord, providing mechanical support and contributing to maintaining a stable environment. CSF is an ideal biosample for neuroscience research due to its proximity to the brain and the presence of various biomarkers reflecting the brain's physiological and pathological states.

Collection methods and challenges

Lumbar puncture is the most common method for collecting CSF. The procedure is generally safe but carries some risks, such as infection, bleeding, and post-lumbar puncture headache. Additionally, the invasiveness of the process and the discomfort experienced by participants may limit its use in specific populations.

Biomarkers and applications

CSF biomarkers have been extensively studied in neurodegenerative diseases, such as Alzheimer's disease (Aβ42, tau, and p-tau) and Parkinson's disease (α-synuclein). Other applications include research in multiple sclerosis, neuroinflammatory conditions, and brain infections.


Overview and relevance to neuroscience research

Blood is a readily accessible, minimally invasive biosample containing a wealth of information related to the nervous system. It comprises various components, such as plasma, serum, red and white blood cells, and platelets, which may contain biomarkers and other molecules of interest.

Blood components and their roles in research

  • Plasma: The liquid component of blood, containing proteins, lipids, and other molecules. It helps study systemic factors influencing the nervous system.

  • Serum: Similar to plasma but without clotting factors, serum can also provide insights into systemic influences on the nervous system.

  • Blood cells: Cellular components, such as leukocytes, can be used to study immune responses in neurological conditions.

Collection methods and challenges

Venipuncture is the most common method for blood collection. While generally safe and well-tolerated, it carries some risks, such as infection and hematoma formation. Proper handling and processing are crucial to obtain reliable results.

Biomarkers and applications

Blood-based biomarkers have been investigated for a variety of neurological diseases, including Alzheimer's disease (Aβ42, tau), Parkinson's disease (α-synuclein), multiple sclerosis (neurofilament light chain), and stroke (D-dimer, C-reactiveprotein). Blood samples are also helpful in studying the genetic basis of neurological disorders, immune responses, and pharmacokinetics of therapeutic agents.

Brain Tissue

Overview and relevance to neuroscience research

Brain tissue samples provide direct information about the brain's cellular and molecular architecture, allowing for the study of disease-specific changes and identifying potential therapeutic targets. They are treasured in research on neurodegenerative diseases, brain tumours, and epilepsy.

Collection methods and challenges

Brain tissue samples can be obtained through biopsy, surgical resection, or post-mortem examination. The invasiveness and risks associated with brain biopsies and surgeries and the limited availability of post-mortem samples make brain tissue a challenging biosample to obtain.

Types of brain tissue samples

  • Fresh-frozen tissue: Preserved by rapid freezing, these samples are optimal for molecular and biochemical analyses.

  • Formalin-fixed, paraffin-embedded (FFPE) tissue: Widely used for histological and immunohistochemical studies.

Applications in neurodegenerative diseases and brain cancer

Brain tissue samples are invaluable in understanding the pathological processes underlying neurodegenerative diseases, such as Alzheimer's and Parkinson's, and identifying potential therapeutic targets for brain tumours, such as glioblastoma.


Overview and relevance to neuroscience research

Saliva is a non-invasive, easily accessible biosample containing various biomolecules, such as proteins, lipids, hormones, and nucleic acids. It has been increasingly recognised as a valuable source of biomarkers for neurological disorders, particularly in relation to stress and neuroendocrine function.

Collection methods and challenges

Saliva can be collected using passive drool or absorbent devices like cotton swabs. Factors affecting saliva composition, such as diurnal variation and hydration status, must be considered to ensure accurate and reliable results.

Biomarkers and applications

Salivary biomarkers, such as cortisol, alpha-amylase, and nerve growth factor, have been studied in relation to stress, mood disorders, and autism spectrum disorders.

Skin Biopsies

Overview and relevance to neuroscience research

Skin biopsies provide access to peripheral nerve fibres and can be used to study small fibre neuropathies and other peripheral nervous system disorders. Additionally, skin-derived fibroblasts can be reprogrammed into induced pluripotent stem cells (iPSCs), offering a valuable tool for modelling neurological diseases in vitro.

Collection methods and challenges

Skin biopsies are typically performed using a punch biopsy technique. Although minimally invasive, the procedure carries risks of infection, scarring, and pain.

Applications in neurodegenerative diseases and peripheral neuropathies

Skin biopsies have been used to investigate small fibre neuropathies, diabetic neuropathy, and hereditary sensory and autonomic neuropathies. Moreover, iPSCs derived from skin fibroblasts have been employed to model neurodegenerative diseases, such as Alzheimer's, Parkinson's, and amyotrophic lateral sclerosis (ALS).

Best Practices in Biosample Collection, Storage, and Handling

Standardisation and quality control

Adherence to standardised biosample collection, processing, and storage protocols is essential to ensure sample integrity, minimise variability, and enhance reproducibility.

Biobanking and long-term storage

Biobanks play a crucial role in preserving biosamples for future use, enabling researchers to access well-annotated, high-quality samples for their studies.

Data management and sharing

Effective data management and sharing practices are essential for maximising the value of clinical biosamples. By implementing secure and standardised data storage systems, researchers can ensure the accessibility, reusability, and interoperability of the data associated with the biosamples.


Summary of key points

The selection of the most suitable clinical biosamples for neuroscience research is critical to obtaining meaningful insights into the nervous system and its associated disorders. Each biosample type, including cerebrospinal fluid, blood, brain tissue, saliva, and skin biopsies, offers unique advantages and applications in studying the nervous system. However, the choice of the ideal sample depends on various factors, such as the research question, sample accessibility, and the invasiveness of the collection method.

Ensuring high-quality and standardised biosample collection, storage, and handling practices is crucial for maximising the scientific outcomes derived from these samples. Biobanking, data management, and sharing practices play a significant role in preserving the integrity of the biosamples and the associated data, enabling researchers to access well-annotated and high-quality samples for their studies.

Future directions and emerging technologies

As neuroscience research progresses, emerging technologies and advancements in analytical methods will continue to shape the landscape of clinical biosamples. Some potential future directions include:

  • Liquid biopsies: These minimally invasive procedures involve analysing circulating biomolecules, such as cell-free DNA, RNA, and extracellular vesicles, in bodily fluids like blood and CSF. Liquid biopsies hold promise for early detection, disease monitoring, and identification of therapeutic targets in neurological disorders.

  • Single-cell sequencing: This powerful technique allows researchers to study the gene expression profiles of individual cells, providing unprecedented insights into cellular heterogeneity within the nervous system. As this technology becomes more accessible, it will enable the identification of rare cell populations and molecular pathways underlying neurological diseases.

  • Wearable devices: Advances in wearable technology offer new opportunities for non-invasive and continuous monitoring of physiological parameters related to the nervous system, such as heart rate variability, sleep patterns, and electroencephalography (EEG) signals. These devices could facilitate real-time tracking of disease progression and response to therapies, improving personalised medicine approaches in neuroscience.

  • Integration of multi-omics data: Combining genomics, transcriptomics, proteomics, and metabolomics data from biosamples can provide a comprehensive view of the molecular mechanisms underlying neurological diseases. Integrative analyses will enable the identification of novel biomarkers and therapeutic targets, paving the way for precision medicine in neuroscience.

The ongoing development of new technologies and methods will enhance our ability to study the dynamic nature of the nervous system and its disorders. As our understanding of the best clinical biosamples and their optimal use grows, we can expect significant advancements in diagnosing, treating, and preventing neurological diseases. 

Please click on the links below to inquire about the Compare Biomarket® range of clinical biospecimens and services suitable for your unique human health research needs.

Latest News

Acute Myeloid Leukaemia (AML) Research

Elucidating Molecular and Genetic Characteristics

Board-Certified Pathology Review

Ensuring FFPE Biosamples are Accurately Characterized

Fresh Viable Tissue

Applications Include Biology, Medicine and Pharmacology

Compare the Biomarket

  • Whatsapp
  • LinkedIn
  • Twitter

Follow us today. 

bottom of page